Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organon for $14.00 per share.